Shareholding disclosure

Novartis AG

Declared position

10%

Threshold

Crossed upwards

Timeline

Published

20.02.2025

Transaction

17.02.2025

Voting rights breakdown

Voting rights acquired10%

Voting rights sold0.689%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

ZA01-000000000PSL2

Beneficial owner

Novartis AG

Declared address

Novartis AG, Basel, CH

2nd trading line buyback transactions

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Novartis AG

Novartis AG20.02.2025ZA01-000000000PSL2

Disclosure summary

Novartis AG disclosed a holding in Novartis AG on the acquisition side, published by SIX Exchange Regulation on 20.02.2025, at 10% of voting rights. Notice category: Single shareholder.

Disclosed position

10%

Voting rights acquired

Voting rights acquired10%

Voting rights sold0.689%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Novartis AG disclosed a holding in Novartis AG, published on 20.02.2025.

Publication date20.02.2025

Transaction date17.02.2025

Issuing companyNovartis AG

Beneficial ownerNovartis AG

Declared addressNovartis AG, Basel, CH

CategorySingle shareholder

Voting rights acquired10%

Voting rights sold0.689%

Below threshold0%

ExchangeXSWX

Notification IDZA01-000000000PSL2

Commercial register

CHE-103.867.266

Registered

Zefix record

Conditions

2nd trading line buyback transactions

Source: SIX Exchange Regulation · Publication date: 20.02.2025

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open